End stage chronic obstructive pulmonary disease

Pneumonologia i Alergologia Polska

Volumn 77, Issue 2, 2009, Pages 173-179

  Ambrosino, Nicolino ^a   Gherardi, Marco ^a   Carpenè, Nicoletta ^a  

^a Respiratory Intensive Care and Pulmonary Diseases Unit   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DYSPNEA; HUMAN; METHODOLOGY; OXYGEN THERAPY; PALLIATIVE THERAPY; PROGNOSIS; QUALITY OF LIFE; REVIEW; SMOKING CESSATION; SOCIAL SUPPORT;

DISEASE PROGRESSION; DYSPNEA; HUMANS; OXYGEN; OXYGEN INHALATION THERAPY; PALLIATIVE CARE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SMOKING CESSATION; SOCIAL SUPPORT;

EID: 69849105878     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Global initiative for chronic obstructive lung disease, Workshop report, global strategy for diagnosis, management, and prevention of COPD. Update Sept. 2005. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute; 2005. Available from: www.goldcopd.com.
2. Celli B.R., Mac'Nee W., Agusti A. et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur. Respir. J. 2004; 23: 932-946.
3. Zielinski J., Bednarek M., Gorecka D. et al. Increasing COPD awareness. Eur. Respir. J. 2006; 27: 833-852.
4. Connors A.F. Jr, Dawson N.V., Thomas C. et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 1996; 154: 959-967.
5. Vitacca M., Bianchi L., Barbano L., Ziliani M., Ambrosino N. Effects of acute on chronic respiratory failure on hypercapnia and. 3-month survival. Chest 2005; 128: 1209-1215.
6. Groenewegen K.H., Schols A.M.W.J., Wouters E.F.M. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124: 459-467.
7. Rivera-Fernandez R., Navarrete-Navarro P., Fernandez-Mondejar E., Rodriguez-Elvira M., Guerrero-Lopez F., Vazquez-Mata G. Project for the epidemiological analysis of critical care patients (PAEEC) group. Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit. Care Med, 2006; 34: 2317-2324.
8. Fabbri L.M., Luppi F., Beghé B., Rabe K.F. Complex chronic comorbidities of COPD. Eur. Respir. J. 2008; 31: 204-212.
9. Pinto-Plata V.M., Mullerova H., Toso J.F. et al. C-reactive protein in patients with COPD, control smokers, and nonsmokers. Thorax 2006; 61: 23-213.
10. Mannino D.M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur. Respir. J. 2008; 32: 962-969.
11. Eickhoff P., Valipour A., Kiss D. et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008; 178: 1211-1218.
12. Restrick L.J., Paul E.A., Braid. G.M., Cullinan P., Moore-Gillon J., Wedzicha J.A. Assessment, and follow up of patients prescribed long term oxygen therapy. Thorax 1993; 48: 708-713.
13. Schols A.MW.J., Wouters E.F.M. Nutrition and. metabolic therapy. In: Donner CF., Ambrosino N, Goldstein R.S. (eds). Pulmonary Rehabilitation. Hodder Arnold, London, 2005, pp 229-235.
14. Schols A.M., Siangan J., Volovics L., Wouters E.F.M. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 1791-1797.
15. Hill K., Geist R., Goldstein RS., Lacasse Y. Anxiety and. depression in end-stage COPD. Eur. Respir, J. 2008; 31: 667-677.
16. Ambrosino N., Bruletti G., Scala V., Porta R., Vitacca M. Cognitive and. perceived health status in patients recovering from an acute exacerbation of COPD. A. controlled study. Intensive Care Med. 2002; 28: 170-177.
17. Albert P., Calverley P.M.A. Drugs (including oxygen) in severe COPD. Eur. Respir. J. 2008; 31: 1114-1124.
18. Drummond B.A., Dasenbrook E.C., Pitz M.W., Murphy D.J., Fan E. Inhaled corticosteroids in patients with stable Chronic Obstructive Pulmonary Disease. A systematic review and metaanalysis. J.A.M.A. 2008; 300: 2407-2416.
19. Sin D.D., Wu L., Anderson J.A. et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005; 60: 992-997.
20. Sin D.D., Man P., Marciniuk D.D. et al. for the ABC (Advair, Biomarkers in COPD) Investigators. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008; 177: 1207-1214.
21. Calverley P.M.A., Anderson J.A, Celli B. et al. for the TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775-789.
22. Cano N.J.M., Pichard C., Eng H.R. et. al. and the Clinical Research Group of the Société Francophone de Nutrition Entérale et Parenterale. C-Reactive Protein and Body Mass Index predict outcome in end-stage respiratory failure.'Chest 2004; 126: 540-546.
23. Singh S., Loke Y.K., Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. A systematic Review and meta-analysis. J.A.M.A. 2008; 300: 1439-1450.
24. Tashkin D.P., Celli B., Senn S. et al. for the UPLIFT Study Investigators, A 4-Year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 1543-1554.
25. van Gestel Y.R.B.M., Hoeks S.E., Sin D.D. et al. Impact of cardioselective b-blockers on mortality in patients with Chronic Obstructive Pulmonary Disease and atherosclerosis. Am.. J. Respir. Crit. Care Med. 2008; 178: 695-700.
26. Mitrouska I., Tzanakis N., Siafakas N.M. Oxygen therapy in chronic obstructive pulmonary disease. Eur. Respir, Mon. 2006; 38: 302-312.
27. Petty T.L., O'Donohue W.J. Jr. Further recommendations for prescribing, reimbursement, technology development, and research in long-term oxygen therapy. Am. J. Respir. Crit. Care Med. 1994; 150: 875-877.
28. Nonoyama M., Brooks D., Lacasse Y., Guyatt G., GoldsteinR. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007; 18: CD005372.
29. Nonoyama M., Brooks D., Guyatt G., Goldstein R. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am. J. Respir. Crit. Care Med. 2007; 176: 343-349.
30. Hanania N.A., Ambrosino N., Calverley P., Cazzola M., Donner CF., Make B. Treatments for COPD, Respir. Med. 2005; 99: S28-S40.
31. Muir J.F., Cuvelier A., T'enang B. European task force on mechanical ventilation COPD. Long-term home nasal intermittent positive pressure ventilation (NIPPV) plus oxygen therapy (LTOT) versus LTOT alone in severe hypercapnic COPD. Preliminary results of a European multicentre trial. Am. J. Respir. Crit. Care Med. 1997; 155: A408.
32. Clini E., Sturani C., Rossi A. et al. and. Rehabilitation and. Chronic Care Study Group, Italian Association of Hospital Pulmonologists (AIPO). The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur. Respir. J. 2002; 20: 529-538.
33. Windisch W. on behalf of the quality of life in home mechanical ventilation study group. Impact of home mechanical ventilation on health-related quality of life Eur. Respir. J. 2008; 32: 1328-1336.
34. Kolodziej M.A., Jensen L., Rowe B., Sin D. Systematic review of noninvasive positive pressure ventilation in severe stable COPD. Eur. Respir. J. 2007; 30: 293-306.
35. Celli B.R., Barnes P.J. Exacerbations of chronic obstructive pulmonary disease. Eur. Respir. J. 2007; 29: 1224-1238.
36. Garcia-Aymerich J., Monsú E., Marrades R.M. et al. and. EFRAM Investigators. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am. J. Respir. Crit. Care Med. 2001; 164: 1002-1007.
37. Esteban A., Ferguson N.D., Meade M.O. et al. Evolution of mechanical ventilation in response to clinical research. Am. J. Respir. Crit. Care Med. 2008; 177:170-177.
38. Ambrosino N., Vagheggini G. Non invasive positive pressure ventilation in the acute care setting: where are we? Eur. Respir. J. 2008; 31: 874-886.
39. Sinuff T., Cook D.J., Keenan S.P. et al. Noninvasive ventilation for acute respiratory failure near the end of life. Crit. Care Med. 2008; 36: 789-794.
40. Nava S., Sturani C., Hartl S. et al. on behalf of the European Respiratory Society Task Force on Ethics and decision-making in end stage lung disease. End-of-life decision-making in respiratory intermediate care units: a European survey. Eur. Respir. J. 2007; 30: 1442-1450.
41. Curtis J.R., Cook D.J., Sinuff T. et al. Noninvasive positive pressure ventilation in critical and palliative care settings: Understanding the goals of therapy. Crit. Care Med. 2007; 35: 932-939.
42. Ambrosino N., Casaburi R., Ford G. et al. Developing concepts in the pulmonary rehabilitation of COPD. Respir. Med. 2008; 102 Suppl 1:S17-26.
43. Nici L., Donner C., Wouters E. et al. on behalf of the ATS/ERS Pulmonary Rehabilitation Writing Committee.American Thoracic Society/European Respiratory Society. Statement on Pulmonary Rehabilitation. Am. J. Respir. Crit. Care Med. 2006; 173: 1390-1413.
44. Carone M., Patessio A., Ambrosino N. et al. Effect of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study. Respir. Med. 2007; 101: 2447-2453.
45. Clini E., Ambrosino N. Early physiotherapy in the respiratory intensive care unit. Respir. Med. 2005; 99: 1096-1104.
46. Porta R., Vitacca M., Gilé L.S. Supported arm training in patients recently weaned from mechanical ventilation. Chest 2005; 128: 2511-2520.
47. Gosselink R., Bott J., Johnson M. et al. Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and. European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically 111 Patients. Intensive Care Med. 2008; 34: 1188-1199.
48. Ambrosino N., Palmiero G., Strambi S. New Approaches in Pulmonary Rehabilitation. Clin. Chest Med. 2007; 28: 629-638.
49. Lederer D.J., Arcasoy S.M. Update in Surgical Therapy for Chronic Obstructive Pulmonary Disease. Clin. Chest Med. 2007; 28:639-653.
50. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N. Engl. J. Med. 2001; 345: 1075-1083.
51. National Emphysema Treatment. Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical, therapy for severe emphysema. N. Engl. J. Med. 2003; 348: 2059-2073.
52. Criner G.J., Scharf S.M., Falk J.A. et al. for the National Emphysema Treatment Trial Research Group. Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema. Am. J. Respir. Crit. Care Med. 2007; 178: 253-260.
53. Washko G.R., Fan V.S., Ramsey S.D. et al. The effect, of lung volume reduction surgery on Chronic Obstructive Pulmonary Disease exacerbations. Am. J. Respir. Crit. Care Med. 2008; 177:164-169.
54. Ingenito E.P., Tsai L.W. Evolving endoscopic approaches for treatment of emphysema. Semin. Thorac. Cardiovasc. Surg. 2007; 19: 181-189.
55. Reilly J., Washko G., Pinto-Plata V. et al. Biological lung volume reduction. A new bronchoscopic therapy for advanced emphysema. Chest 2007; 131: 1108-1113.
56. Trulock E.P., Christie J.D., Edwards L.B. et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J. Heart. Lung Transplant. 2007; 26: 782-795.
57. Corris P.A., Christie J.D. Update in transplantation 2007. Am. J. Respir. Crit. Care Med. 2008; 15: 1062-1067.
58. Ambrosino N., Bruschi C., Callegari G. et al. Time course of exercise capacity, and skeletal and respiratory muscle performance after heart-lung transplantation. Eur. Respir. J. 1996; 9: 1508-1514.
59. Gay S.E., Martinez F.J. Pulmonary rehabilitation and. transplantation. In: Donner C.F., Ambrosino N, Goldstein R.S, (eds), Pulmonary rehabilitation. Arnold Pub-London 2005; 304-311.
60. ISHLT Transplant. Registry Quarterly Reports. Available at http://www.ishlt.org/regist.ries/quart.erlyDat.aReport.asp. Accessed 2008, December 16.
61. Curtis J.R. Palliative and end-of-life care for patients with severe COPD. Eur. Respir. J. 2008; 32: 796-803.
62. Ambrosino N., Simonds A. The clinical management in extremely severe COPD. Respir. Med. 2007; 101: 1613-1624.
63. Luce J.M., Luce J.A. Management of dyspnea in patients with far-advanced lung disease. J.A.M.A. 2001; 285: 1331-1337.
64. American Thoracic Society. Official Statement, 1998. Dyspnea: mechanisms, assessment, and management; a consensus statement. Am. J. Respir. Crit. Care Med. 1999; 159: 321-340.
65. Wilcock A., Walton A., Manderson C. et al. Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer. Thorax. 2008; 63: 872-875.
66. Jensen D., Amjadi K., Harris-McAllister V., Webb K.A., O'Donneil D.E. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Thorax 2008; 63: 606-613.
67. Palange P., Crimi E., Pellegrino R., Brusasco V. Supplemental oxygen and heliox: «new» tools for exercise training in chronic obstructive pulmonary disease. Curr. Opin. Puim. Med. 2005; 11: 145-148.
68. The effect of helium and oxygen on exercise performance in chronic obstructive pulm.ona.ry disease. A rand.om.ized cross-over trial. Am. J. Respir. Crit. Care Med. 2006; 173: 865-870.
69. Xu W., Collet J.P., Shapiro S. et al. Independent effect of depression and anxiety on Chronic Obstructive Pulmonary Disease exacerbations and hospitalizations. Am. J. Respir. Crit. Care Med. 2008; 178: 913-920.
70. Paz-Diaz H., Montes de Oca M., Lopez J.M., Celli B.R. Pulmonary rehabilitation improves depression, anxiety, dyspnea and. health status in patients with COPD. Am. J. Phys, Med. Rehabil. 2007; 86: 30-36.
71. Qaseem A., Snow V., Shekelle P., Casey D.EJr, Cross J.T., Owens D.K. for the clinical efficacy assessment, subcommittee of the American College of Physicians. Evidence-Based interventions to improve the palliative care of pain, dyspnea, and depression at. the end. of life: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 2008; 148: 141-146.
72. Truog R.D., Campbell M.L., Curtis J.R. et al. Recommendations for end-of-life care in the intensive care unit: A consensus statement by the American College of Critical Care Medicine. Crit. Care. Med. 2008; 36: 953-963.
73. Lorenz K.A., Lynn J., Dy S.M. et al. Evidence for improving palliative care at. the end of life: a systematic review. Ann. Intern. Med. 2008; 148: 147-159.
74. Clini E.M., Ambrosino N. Nonpharmacological treatment and relief of symptoms in COPD. Eur. Respir. J. 2008; 32: 218-228.